跳到正文

Taysha Gene Therapies, Inc.(TSHA)内部人交易:高管与董事近期交易

过去 18 个月,共有 8 位内部人为 Taysha Gene Therapies, Inc.(TSHA)报告了 34 笔 Form 4 交易(最近一笔 2026-07-10)。

日期内部人职务类型股数市值
2026-07-10Nagendran SukumarPresident and Head of R&D卖出200,000$1.2M
2026-06-02Long Alison S董事买入21,335$0
2026-06-02Donenberg Phillip B.董事买入21,335$0
2026-06-02Stalfort John A III董事买入21,335$0
2026-06-02Sepp-Lorenzino Laura董事买入21,335$0
2026-04-13Nagendran SukumarPresident and Head of R&D买入19,021$32,526
2026-04-13Nagendran SukumarPresident and Head of R&D卖出200,000$892,000
2026-02-06Alam KamranCHIEF FINANCIAL OFFICER卖出1,655$7,481
2026-01-27Nagendran SukumarPresident and Head of R&D卖出89,132$423,377
2026-01-27Alam KamranCHIEF FINANCIAL OFFICER卖出23,849$109,944
2026-01-27Alam KamranCHIEF FINANCIAL OFFICER卖出78,968$375,098
2026-01-27Nagendran SukumarPresident and Head of R&D卖出26,918$124,092
2026-01-27Nolan Sean P.Chief Executive Officer卖出136,789$649,748
2026-01-27Nolan Sean P.Chief Executive Officer卖出41,312$190,448
2026-01-14Alam KamranCHIEF FINANCIAL OFFICER买入359,000$0
2026-01-14Nagendran SukumarPresident and Head of R&D买入111,324$77,927
2026-01-14Nagendran SukumarPresident and Head of R&D买入88,676$151,636
2026-01-14Nagendran SukumarPresident and Head of R&D卖出200,000$942,000
2026-01-14Nagendran SukumarPresident and Head of R&D买入427,000$0
2026-01-14Nolan Sean P.Chief Executive Officer买入1.0M$0
2025-12-01Nagendran SukumarPresident and Head of R&D买入70,172$49,120
2025-12-01Nagendran SukumarPresident and Head of R&D买入39,953$68,320
2025-12-01Nagendran SukumarPresident and Head of R&D卖出110,125$523,094
2025-12-01Nagendran SukumarPresident and Head of R&D买入260,047$444,680
2025-12-01Nagendran SukumarPresident and Head of R&D卖出260,047$1.2M

来源:SEC Form 4 申报文件 · 截至 2026-07-10